MassMutual Private Wealth & Trust’s Alto Neuroscience ANRO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.09K	Buy	+121	New	+$3.63K	﹤0.01%	1793

Other funds holding ANRO

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

MassMutual Private Wealth & Trust's ANRO Position: Q3 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Alto Neuroscience (ANRO) in Q3 2026: 121 shares worth $3.09K. The stake represents ﹤0.01% of the portfolio and ranks #1793 among its holdings.

65 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

MassMutual Private Wealth & Trust held 121 shares of Alto Neuroscience worth $3.09K as of Q3 2026.
Alto Neuroscience was a new MassMutual Private Wealth & Trust position in Q3 2026.
Alto Neuroscience made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1793 holding.
65 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.